Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.86
Delayed Data
As of Aug 31
 +0.07 / +0.90%
Today’s Change
6.59
Today|||52-Week Range
11.71
-10.27%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close7.79
Today’s open7.78
Day’s range7.76 - 7.97
Volume348,329
Average volume (3 months)540,890
Market cap$391.5M
Dividend yield--
Data as of 08/31/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+18.75%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio25.2
Price/Sales3.42
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.31-1.14%
PRQRProQR Therapeutics N...+0.72+4.31%
VSARVersartis Inc-0.28-2.11%
ADMSAdamas Pharmaceutica...-0.55-2.67%
Data as of 08/31/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.14
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

Partner Offers